17 September 2026
Cancers | Highly Cited Special Issues in 2025 Related to “Cancer Drug Development”
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to share the highly cited Special Issues in 2025 related to “Cancer Drug Development” in Cancers (ISSN 2072-6694).
The list of highly cited Special Issues can be viewed below:
1. “Mechanisms of Therapy Resistance in Cancers”
Guest Editor: Dr. Birandra K. Sinha

2. “Anesthesia and Cancer Recurrence: A New Sight”
Guest Editor: Dr. Lucillia Bezu

3. “Research on Targeted Drugs in Cancer”
Guest Editors: Dr. Bertal Aktas and Dr. Marjorie E. Zettler

4. “Recent Advances in PROteolysis TArgeting Chimeras (PROTACs)”
Guest Editors: Dr. Dhimant Desai and Prof. Dr. Mourad Zerfaoui

5. “Tissue-Agnostic Drug Development in Cancer (2nd Edition)”
Guest Editors: Dr. Kyaw Thein and Dr. Shivaani Kummar

6. “Cancer Drug Discovery and Development Targeting Epigenetics, Metabolism, and DNA Repair”
Guest Editors: Dr. Aditi Jain and Dr. Vikas V. Dukhande

We invite you to read and submit relevant papers to the journal Cancers using the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office